Dutasteride Cuts Risk of Prostate Biopsy-Related UTIs
In a study, use of the medication was associated with a significant 61% decreased risk.
AUA 2016 Annual Meeting
Prostate Cancer Risk Not Increased With Testosterone Therapy
In fact, some data suggest treatment may reduce prostate cancer incidence and aggressiveness.
Water Vapor Ablation Eases BPH/LUTS, Preserves Sexual Function
Significant improvements in lower urinary tract symptoms are durable to 24 months, data show.
High PSA Predicts Elevated Risk of Lower Urinary Tract Symptoms
LUTS is 49% more likely to develop in men with a PSA level above 6 ng/mL versus 4 ng/mL or less.
Apology Laws Found to Speed Up Malpractice Litigation
Physician expressions of sympathy and regret appear to encourage quicker settlements.
Prostatic Urethral Lift Benefits Confirmed
New data show that the minimally invasive procedure is superior overall to TURP for treating BPH-related lower urinary tract symptoms.
Specialists More Likely to Prescribe Newer OAB Drugs Initially
Urologists and gynecologists are 49% and 30% more likely than primary care doctors to prescribe second-generation agents.
Bladder Cancer Risk Higher Following Prostate Radiotherapy
The increased risk occurs more than 10 years after treatment and most pronounced in men who undergo brachytherapy.
High-Risk Prostate Cancer Linked to Poverty
In a study of African-American radical prostatectomy patients, low income predicted a higher risk of advanced stage or aggressive tumors.
Gender Differences Found in Bladder Cancer Treatment, Survival
Cancer-specific survival at 5 years was 76.9% for men and 71.5% for women.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in AUA 2016 Bladder/Kidney Cancer
Loading... 
Loading...